Helix
Sarah Bobulsky is currently the Chief Financial Officer at Helix since April 2016. Prior to that, Sarah held various roles in commercial, strategy, and business operations at the same company. Before joining Helix, Sarah worked at EY as a Vice President in the Life Sciences, Commercial Advisory Services. Sarah began their career as an Associate at Leerink Swann Strategic Advisors and The Lucas Group. Sarah graduated from Brown University with a Bachelor of Arts in Economics.
This person is not in any offices
Helix
9 followers
Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.